Lab Automation Software: Page 3

BrightInsight launches digital diagnostics platform at AACC

By LabPulse.com staff writers

The platform consists of four tools -- Proxy Agent, Analytics Dashboards, Integration Middleware, and Workflow Portals -- for the IVD manufacturer and the lab, providing an end-to-end platform that streamlines workflows, according to BrightInsight.

July 24, 2022

Health Note closes $17 million financing round

By LabPulse.com staff writers

The company has a preclinical intake automation platform that uses digital patient intake to prepare clinical notes for providers ahead of patient visits.

July 21, 2022

Etiometry, Radiometer partner to enhance NICU workflows

By LabPulse.com staff writers

The partnership pairs Etiometry's platform for creating holistic views across the patient care continuum with Radiometer's transcutaneous monitoring (TCM) system for monitoring ventilation of neonatal patients.

June 29, 2022

LigoLab rolls out software upgrade

By LabPulse.com staff writers

A new Web-based feature – called Web Connect – enables physicians and other laboratory clients to remotely place orders, retrieve lab reports, and track the status of a case in real time, according to the vendor.

June 28, 2022

FDA warns about Illumina NGS cybersecurity vulnerability

By Leo O'Connor

The instruments may be specified for research use only or for clinical diagnostic use in sequencing a person's DNA or testing for various genetic conditions.

June 1, 2022

Proscia, Siemens ink digital pathology deal

By Melissa Busch

Under the deal, Siemens Healthineers will expand its enterprise imaging offering into the global digital pathology market using Proscia’s Concentriq Dx platform. The agreement with Proscia enables Siemens Healthineers to expand into one of the few remaining areas of healthcare that is left to begin experiencing the full benefits of digitization.

March 16, 2022

SeekIn receives CE Mark for cancer detection kit

By LabPulse.com staff writers

The company has an artificial intelligence (AI)-based platform that uses private and public data to identify weak cancer DNA and protein signals in the blood and trace them back to a tissue of origin. SeekIn also has patents on algorithms to reduce background noise and reveal cancer signals in blood.

February 24, 2022

Paige links with Flagship on biomarker analysis tools

By LabPulse.com staff writers

Users of Paige Platform will be able to directly launch Flagship's TissueInsight software for quantifying programmed cell death ligand 1 (PD-L1) expression in immunohistochemistry tissue samples. TissueInsight gives CLIA-reportable PD-L1 results, as well as data about the tumor microenvironment, such as information about macrophages and tumor-infiltrating lymphocytes.

February 17, 2022

Agilent acquires Virtual Control's lab AI technology

By LabPulse.com staff writers

Specifically, ACIES will be used with liquid chromatography/mass spectrometry (LC/MS) and gas chromatography and MS (GS/MS) instruments. It automates the labor-intensive task of GS/MS data analysis, improving efficiency in the laboratory workflow from sampling to reporting, Agilent said.

February 16, 2022

ContextVision prepares for spinoff of digital pathology arm

By LabPulse.com staff writers

The company is also making other changes to its executive lineup. Katarina Flood will be the firm's chief services officer; Ann-Sofi Hoff, its chief product officer; Gunnar Läthén, its chief technology officer; and Markus Hökerberg as its new chief financial officer.

February 13, 2022

Scopio completes $50M funding round

By LabPulse.com staff writers

The company's workflow digitizes and analyzes blood samples. Its X100 digital slide-scanning device uses computational photography to image entire sample slides and zoom in on individual cells. Its full-field peripheral blood smear application also supports detection, preclassification, and quantification for blood cells. The company is also working on artificial intelligence (AI) applications.

February 10, 2022

SLAS 2022: Diagnostics tech should be based on clinical need

By Leah Sherwood

Traditionally, scientists and engineers create a technology, find a biological application for it, and publish it in a big academic journal. For companies, the cycle is a bit different: a company creates a technology, most likely for life sciences research, and then years (if not decades) later, someone discovers a clinical application for it.

February 9, 2022

Previous Page

Page 3 of 11

Next Page